Equities

Medicon Hellas SA

Medicon Hellas SA

Actions
  • Price (EUR)2.83
  • Today's Change-0.10 / -3.41%
  • Shares traded16.79k
  • 1 Year change-21.39%
  • Beta0.5975
Data delayed at least 20 minutes, as of Jun 03 2024 14:50 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medicon Hellas SA is a Greece-based company active in the health equipment sector. Its activities include research and development, production, and import and export of diagnostic products; the development of laboratory information systems; the import and distribution of in vitro diagnostics and automated analytical systems, such as Olympus for clinical chemistry, immunochemistry and lab automation, and Nihon Kohden for hematology, and the provision of cosmetic and body care products, such as make-up, anti-ageing and skin care products under the brand name Miss Beaute. Its laboratory information systems products include: Gi-Lab, which is a management system for medical laboratories; Gi-Maxima, a management program for medical centers, and Gi-Blood, which is an application that helps to connect various blood donation networks. On December 6, 2013, it merged by absorption of its subsidiary, Medicon Ltd.

  • Revenue in EUR (TTM)19.86m
  • Net income in EUR2.06m
  • Incorporated1988
  • Employees98.00
  • Location
    Medicon Hellas SAMelitona 5-7, GerakasATHINA 153 44GreeceGRC
  • Phone+30 2 106606000
  • Fax+30 2 106612666
  • Websitehttps://www.mediconsa.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ScandiDos AB5.70m-424.96k8.99m34.00--2.37--1.58-0.1063-0.10631.430.75880.95730.47877.39---7.14-13.82-13.39-23.9582.5482.49-7.45-17.090.4511-2.630.00--6.704.01-24.27--4.18--
Nanexa AB2.53m-6.19m11.20m19.00--1.37--4.42-0.8143-0.81430.32520.68540.2069-33.452.261,521,474.00-50.54-40.77-66.82-48.77124.7077.27-244.28-532.262.14--0.0193--925.42147.00-30.44--39.10--
Ortivus AB6.85m-1.81m11.27m42.00--8.08--1.65-0.4655-0.46551.760.35291.003.364.761,953,650.00-26.44-2.41-51.70-4.6333.8842.46-26.39-1.770.5256--0.4544---19.5510.00-409.66--67.43--
Medinice SA52.68k-1.19m11.30m16.00--1.50--214.53-0.8125-0.81250.03615.130.0057--0.339914,062.50-12.78-12.47-13.14-12.9633.3362.64-2,254.22-1,404.30----0.015---10.71189.32-4.41--177.91--
Spineguard SA4.31m-4.18m12.13m24.00--2.01--2.81-0.1084-0.10840.11180.12700.38271.284.68179,700.00-37.12-23.69-52.43-42.7372.8975.60-97.00-45.021.73-13.510.3384---22.98-10.65-74.81--89.42--
Neola Medical AB0.00-792.11k12.23m7.00--1.82-----0.1536-0.15360.001.090.00----0.00-11.63-17.04-12.52-18.46--4,237.20---5,258.78----0.00------12.97--55.46--
aap Implantate AG-100.00bn-100.00bn12.23m111.00--0.7827----------1.58-----------28.07---34.07--90.66---74.070.9396--0.1584---5.341.10-1.67---25.10--
Dignitana AB7.51m-1.62m12.67m28.00--46.71--1.69-0.2487-0.24871.150.03841.663.3514.613,175,519.00-35.81-42.21-97.80-68.9169.1166.09-21.55-57.290.3234-8.840.8571--17.9020.5922.52---15.31--
Laboratoires Euromedis SA49.54m-5.51m12.94m194.00--0.4638--0.2611-1.84-1.8416.469.700.82833.544.88255,371.10-9.19---11.45--32.67---11.09--3.57-12.830.2875---51.58---362.99------
Medicon Hellas SA19.86m2.06m12.95m98.006.300.763.360.65190.46520.46524.493.860.6111.882.16--6.736.488.018.1572.1474.4411.0211.21--11.500.3853---3.4110.33-16.688.0824.76--
BibbInstruments AB0.00-960.92k13.48m----4.93-----0.4379-0.43790.001.180.00-------32.19-39.57-34.83-42.71--59.36---8,032.40----0.00------2.72---1.94--
Implanet SA7.45m-6.68m13.62m41.00------1.83-0.1704-0.17040.1933-0.00420.59310.90834.19182,973.00-53.17-37.44-159.90-86.7456.8359.59-89.65-67.430.2932-24.761.03---7.242.08-88.59---2.20--
Ivision Tech SpA9.37m53.62k13.88m146.00258.732.128.471.480.00770.00771.350.9418------64,151.30--------57.67--0.5725--1.222.380.4058--18.59---81.01------
Inspiration Healthcare Group PLC48.28m-646.34k14.03m210.00--0.3397.100.2907-0.0081-0.00810.6030.51630.78792.324.76195,619.00-1.056.14-1.257.6045.5947.42-1.346.001.50-0.12890.2317--0.445821.62-93.58-25.9752.54--
Theraclion SA1.87m-4.88m16.69m30.00--2.46--8.93-0.1362-0.13620.05040.14810.10210.2821.2366,785.00-26.65-40.08-35.36-59.9654.2152.19-260.94-276.132.50-56.170.2546---16.58-12.66-32.02--11.77--
Iconovo AB742.03k-3.71m16.80m29.00--1.43--22.65-3.68-3.680.7038.450.0554--1.24292,079.00-27.74-25.43-30.85-28.24234.21134.57-500.63-215.16----0.0666---58.65-9.884.71--34.70--
Data as of Jun 03 2024. Currency figures normalised to Medicon Hellas SA's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.